BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
18.40
-0.77 (-4.02%)
Nov 20, 2024, 4:00 PM EST - Market closed
BioAge Labs Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 16.54 | 14.51 | 9.45 |
| Research & Development | 49.89 | 33.89 | 30.52 |
| Operating Expenses | 66.43 | 48.4 | 39.97 |
| Operating Income | -66.43 | -48.4 | -39.97 |
| Interest Expense | -4.61 | -7.79 | -0.24 |
| Interest & Investment Income | 5.91 | 2.43 | 0.47 |
| EBT Excluding Unusual Items | -60.6 | -53.76 | -39.75 |
| Other Unusual Items | -10.34 | -10.09 | 0.02 |
| Pretax Income | -70.94 | -63.85 | -39.72 |
| Net Income | -70.94 | -63.85 | -39.72 |
| Net Income to Common | -70.94 | -63.85 | -39.72 |
| Shares Outstanding (Basic) | 2 | 2 | 2 |
| Shares Outstanding (Diluted) | 2 | 2 | 2 |
| Shares Change (YoY) | 28.09% | 0.06% | - |
| EPS (Basic) | -33.13 | -38.17 | -23.76 |
| EPS (Diluted) | -33.13 | -38.17 | -23.76 |
| Free Cash Flow | -55.23 | -37.53 | -36.28 |
| Free Cash Flow Per Share | -25.79 | -22.43 | -21.70 |
| EBITDA | -66.27 | -48.24 | -39.84 |
| D&A For EBITDA | 0.16 | 0.16 | 0.13 |
| EBIT | -66.43 | -48.4 | -39.97 |
Source: S&P Capital IQ. Standard template.
Financial Sources.